A probable role for vaccines containing thimerosal in thimerosal hypersensitivity
- 1 March 1991
- journal article
- Published by Wiley in Contact Dermatitis
- Vol. 24 (3) , 178-182
- https://doi.org/10.1111/j.1600-0536.1991.tb01694.x
Abstract
We patch tested 141 patients with 0.05% aq thimerosal and 222 patients with 0.05% aq, mercuric chloride, including 63 children. The frequency of positive patch test reactions to thimerosal was 16.3%. There was a marked preponderance in the young age groups after vaccination, while none of 3h infants (aged 3–48 months) reacted lo thimerosal positive reactions to mercuric chloride were found in 23 (10.4%) of 223 patients. We also sensitized guinea pigs with diphtheria‐pertussis‐tetanus (DPT) vaccine containing 0.01% thimerosal and succeeded in inducing hypersensitivity to thimerosal. From patch testing in humans and animal experiments, it is suggested that 0.01% thimerosal in vaccines can sensitize children, and that hypersensitivity to thimerosal is due to the throsaticylic part of the molecule and correlates with photosensitivity to piroxicam.Keywords
This publication has 6 references indexed in Scilit:
- Sulfhydryl Drug‐induced Eruption: A Clinical and Histological StudyThe Journal of Dermatology, 1990
- Thiomersal allergy and vaccination reactionsContact Dermatitis, 1988
- Piroxicam-induced photosensitive dermatitisJournal of the American Academy of Dermatology, 1986
- Reactions to merthiolate in infantsContact Dermatitis, 1986
- Merthiolate hypersensitivity and vaccinationContact Dermatitis, 1980
- Merthiolate allergy: a nationwide iatrogenic sensitizationActa Dermato-Venereologica, 1977